DexCom, Inc. (DXCM)
NASDAQ: DXCM · Real-Time Price · USD
89.06
-0.29 (-0.32%)
At close: Jul 30, 2025, 4:00 PM
84.23
-4.83 (-5.42%)
After-hours: Jul 30, 2025, 7:11 PM EDT
DexCom Stock Forecast
Stock Price Forecast
The 18 analysts that cover DexCom stock have a consensus rating of "Strong Buy" and an average price target of $99, which forecasts a 11.16% increase in the stock price over the next year. The lowest target is $85 and the highest is $115.
Price Target: $99 (+11.16%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for DexCom stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 7 | 7 | 8 | 9 | 7 |
| Buy | 7 | 7 | 8 | 8 | 8 | 8 |
| Hold | 3 | 3 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 17 | 17 | 18 | 19 | 20 | 18 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Hold Maintains $93 → $98 | Hold | Maintains | $93 → $98 | +10.04% | Jul 30, 2025 |
| Mizuho | Mizuho | Buy Maintains $95 → $100 | Buy | Maintains | $95 → $100 | +12.28% | Jul 16, 2025 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $82 → $89 | Hold | Maintains | $82 → $89 | -0.07% | Jul 15, 2025 |
| Truist Securities | Truist Securities | Strong Buy Initiates $102 | Strong Buy | Initiates | $102 | +14.53% | Jun 16, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Initiates $104 | Strong Buy | Initiates | $104 | +16.78% | May 30, 2025 |
Financial Forecast
Revenue This Year
4.71B
from 4.03B
Increased by 16.74%
Revenue Next Year
5.43B
from 4.71B
Increased by 15.42%
EPS This Year
2.07
from 1.42
Increased by 45.41%
EPS Next Year
2.59
from 2.07
Increased by 24.96%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 4.9B | 5.9B | 6.9B | ||
| Avg | 4.7B | 5.4B | 6.2B | ||
| Low | 4.5B | 5.0B | 5.4B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 22.5% | 24.7% | 26.9% | ||
| Avg | 16.7% | 15.4% | 14.7% | ||
| Low | 11.0% | 5.5% | -0.9% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 2.25 | 3.08 | 4.11 | ||
| Avg | 2.07 | 2.59 | 3.19 | ||
| Low | 1.91 | 2.25 | 2.56 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 57.8% | 48.6% | 58.7% | ||
| Avg | 45.4% | 25.0% | 23.2% | ||
| Low | 34.2% | 8.8% | -1.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.